Literature DB >> 10731242

A critical review of 'a critical review': the methodology of the 1993 World Development Report, 'Investing in Health'.

P Musgrove1.   

Abstract

Since its publication in 1993, the World Bank's World Development Report, Investing in Health, has been subjected to much criticism, particularly over the way it proposes to measure the health losses summarized in the concept of the 'burden of disease', and to establish priorities for health interventions according to the reduction in mortality and disability they could produce and what they would cost. Some of these criticisms are justified, and are recognized by the WDR; others arise from misunderstanding or misapplication of the concepts. Sifting these criticisms to arrive at a better understanding requires looking at what kind of analysis is involved, how the subjective elements of the exercise were determined, and how they can be used to choose which interventions deserve priority when a country cannot meet all its citizens' health needs.

Mesh:

Year:  2000        PMID: 10731242     DOI: 10.1093/heapol/15.1.110

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  4 in total

1.  Public health and policy issues of hernia surgery in Africa.

Authors:  Andrew N Kingsnorth; Michael G Clarke; Samuel D Shillcutt
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

Review 2.  Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.

Authors:  Samuel D Shillcutt; Damian G Walker; Catherine A Goodman; Anne J Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  The burden of human African trypanosomiasis.

Authors:  Eric M Fèvre; Beatrix V Wissmann; Susan C Welburn; Pascal Lutumba
Journal:  PLoS Negl Trop Dis       Date:  2008-12-23

Review 4.  Cost-effectiveness of interventions to prevent disability in leprosy: a systematic review.

Authors:  Natasja H J van Veen; Paul McNamee; Jan Hendrik Richardus; W Cairns S Smith
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.